Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (260)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
38
2023
3049
1.790
 Why?
Mutation
21
2022
1504
1.740
 Why?
High-Throughput Nucleotide Sequencing
5
2021
206
1.060
 Why?
Translocation, Genetic
14
2021
287
1.030
 Why?
Oncogenes
2
2018
63
0.790
 Why?
Biliary Tract Neoplasms
1
2018
8
0.640
 Why?
Cholangiocarcinoma
1
2018
30
0.630
 Why?
Gene Expression Profiling
14
2022
1141
0.610
 Why?
Genomics
8
2022
313
0.580
 Why?
Proto-Oncogene Proteins B-raf
3
2022
92
0.560
 Why?
Gene Expression Regulation, Neoplastic
11
2022
868
0.540
 Why?
Prognosis
15
2021
2126
0.440
 Why?
Brain Neoplasms
3
2023
285
0.430
 Why?
Gene Dosage
5
2020
92
0.420
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
1060
0.410
 Why?
Plasma Cells
4
2021
239
0.400
 Why?
Genetic Predisposition to Disease
5
2018
570
0.400
 Why?
Genome, Human
4
2021
131
0.380
 Why?
Evolution, Molecular
2
2021
103
0.380
 Why?
Liver Neoplasms
3
2022
352
0.370
 Why?
DNA Mutational Analysis
7
2020
217
0.360
 Why?
Humans
51
2023
54391
0.350
 Why?
Thalidomide
5
2019
398
0.350
 Why?
DNA Copy Number Variations
4
2021
114
0.350
 Why?
In Situ Hybridization, Fluorescence
11
2023
278
0.340
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
108
0.320
 Why?
Software
2
2021
297
0.320
 Why?
Neoplasm Recurrence, Local
3
2021
645
0.300
 Why?
Carcinoma, Hepatocellular
2
2022
203
0.290
 Why?
Chromosome Aberrations
6
2022
316
0.290
 Why?
Polymorphism, Single Nucleotide
3
2018
552
0.280
 Why?
Epigenesis, Genetic
4
2018
399
0.270
 Why?
Clonal Evolution
2
2019
60
0.270
 Why?
Immunoglobulin Heavy Chains
3
2014
54
0.260
 Why?
Chromosomes, Human, Pair 1
2
2019
113
0.260
 Why?
Neoplasm Proteins
3
2017
360
0.250
 Why?
Disease Progression
8
2021
915
0.240
 Why?
Gene Regulatory Networks
2
2022
124
0.240
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
22
0.230
 Why?
Central Nervous System Neoplasms
1
2023
57
0.220
 Why?
Polycomb Repressive Complex 2
2
2021
50
0.220
 Why?
Chromosomes, Human, Pair 14
5
2014
76
0.220
 Why?
Exome
4
2017
51
0.220
 Why?
Male
25
2021
27347
0.210
 Why?
Female
26
2021
28471
0.210
 Why?
STAT2 Transcription Factor
1
2021
7
0.210
 Why?
STAT1 Transcription Factor
1
2021
27
0.210
 Why?
Li-Fraumeni Syndrome
1
2021
13
0.210
 Why?
Germ-Line Mutation
2
2021
68
0.210
 Why?
Hematologic Neoplasms
1
2023
100
0.210
 Why?
Genome-Wide Association Study
3
2018
190
0.200
 Why?
Middle Aged
17
2021
13082
0.200
 Why?
Aged
15
2021
10060
0.200
 Why?
Japan
2
2018
26
0.200
 Why?
Gene Frequency
2
2017
120
0.190
 Why?
Ecosystem
1
2021
90
0.180
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
14
0.180
 Why?
Leukemia, Plasma Cell
1
2020
34
0.180
 Why?
Aged, 80 and over
9
2021
3431
0.180
 Why?
Glioblastoma
1
2021
99
0.180
 Why?
Cell Cycle
1
2021
275
0.180
 Why?
DNA Methylation
3
2016
575
0.180
 Why?
Neoplasms
2
2020
1322
0.180
 Why?
Chromosomal Instability
1
2019
17
0.180
 Why?
Genes, myc
1
2019
47
0.170
 Why?
Chromosomes, Human, Pair 4
3
2014
30
0.170
 Why?
Diploidy
2
2017
30
0.170
 Why?
Chromosomes, Human, Pair 11
3
2014
54
0.170
 Why?
Cell Survival
2
2018
657
0.160
 Why?
INDEL Mutation
1
2018
5
0.160
 Why?
Italy
1
2018
24
0.160
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
14
0.160
 Why?
Mutagenesis
1
2018
77
0.160
 Why?
Genes, Tumor Suppressor
2
2021
85
0.160
 Why?
Adult
13
2021
14207
0.160
 Why?
Chromosomes, Human, Pair 5
1
2017
16
0.160
 Why?
Histone-Lysine N-Methyltransferase
2
2016
58
0.160
 Why?
Transcriptional Elongation Factors
1
2017
28
0.150
 Why?
Transcriptome
4
2021
346
0.150
 Why?
Enhancer Elements, Genetic
1
2017
64
0.150
 Why?
Chromosomes, Human
1
2017
45
0.150
 Why?
Reproducibility of Results
1
2021
1301
0.150
 Why?
Melanoma
1
2020
313
0.150
 Why?
B-Lymphocytes
2
2016
176
0.140
 Why?
Neoplasms, Multiple Primary
1
2016
45
0.140
 Why?
Hepatocytes
1
2018
214
0.140
 Why?
Immunologic Factors
1
2017
130
0.140
 Why?
Neoplasm Metastasis
1
2016
252
0.140
 Why?
Melphalan
2
2013
184
0.130
 Why?
Oligodendroglioma
1
2015
10
0.130
 Why?
Endoribonucleases
1
2015
15
0.130
 Why?
ras Proteins
1
2015
70
0.130
 Why?
Sequence Analysis, DNA
2
2016
274
0.130
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
44
0.130
 Why?
Endoplasmic Reticulum Stress
1
2015
42
0.130
 Why?
Survival Rate
4
2020
954
0.130
 Why?
SMN Complex Proteins
1
2014
4
0.130
 Why?
Skin Neoplasms
1
2020
532
0.120
 Why?
Survival Analysis
5
2015
736
0.120
 Why?
RNA Processing, Post-Transcriptional
1
2014
29
0.120
 Why?
Mutation Rate
3
2021
40
0.120
 Why?
Cyclin D
1
2013
20
0.120
 Why?
Chromosome Deletion
2
2011
150
0.120
 Why?
Signal Transduction
5
2022
1752
0.120
 Why?
Kaplan-Meier Estimate
4
2018
514
0.120
 Why?
Transcription Factors
2
2015
622
0.120
 Why?
Genes, erbB-1
1
2013
9
0.120
 Why?
RNA, Neoplasm
1
2013
54
0.120
 Why?
Nerve Tissue Proteins
1
2015
200
0.110
 Why?
Precursor Cells, B-Lymphoid
1
2013
9
0.110
 Why?
Chromosome Breakage
1
2013
19
0.110
 Why?
Germinal Center
1
2013
23
0.110
 Why?
Cell Line, Tumor
4
2022
1551
0.110
 Why?
RNA Splicing
3
2021
38
0.110
 Why?
Repressor Proteins
1
2014
165
0.110
 Why?
Genetic Heterogeneity
1
2012
22
0.110
 Why?
Cell Transformation, Neoplastic
1
2013
200
0.110
 Why?
DNA-Binding Proteins
1
2015
462
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
28
0.100
 Why?
Acetyltransferases
1
2011
23
0.100
 Why?
Chromosomes, Human, Pair 17
1
2011
43
0.100
 Why?
RNA, Messenger
1
2015
1203
0.100
 Why?
DNA, Neoplasm
3
2018
171
0.100
 Why?
Cell Proliferation
3
2022
1097
0.100
 Why?
Antineoplastic Agents
3
2018
1300
0.100
 Why?
Multivariate Analysis
3
2021
643
0.090
 Why?
TOR Serine-Threonine Kinases
1
2010
85
0.090
 Why?
Remission Induction
2
2021
222
0.090
 Why?
Clone Cells
2
2021
89
0.090
 Why?
Tumor Suppressor Protein p53
1
2011
251
0.090
 Why?
Phenotype
3
2022
819
0.090
 Why?
MicroRNAs
1
2013
386
0.080
 Why?
Alleles
2
2021
277
0.080
 Why?
Spliceosomes
2
2021
10
0.080
 Why?
Transcriptional Activation
2
2021
134
0.080
 Why?
DNA
1
2012
581
0.080
 Why?
Follow-Up Studies
3
2020
2390
0.080
 Why?
Genomic Instability
2
2018
95
0.070
 Why?
Epigenomics
2
2017
67
0.070
 Why?
Risk Factors
3
2021
3937
0.070
 Why?
Loss of Heterozygosity
2
2018
97
0.070
 Why?
Disease-Free Survival
2
2019
488
0.060
 Why?
Treatment Outcome
4
2019
5612
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.060
 Why?
Protein Binding
2
2017
736
0.060
 Why?
Genotype
2
2017
600
0.060
 Why?
Dexamethasone
2
2019
435
0.060
 Why?
Liver
2
2022
1226
0.060
 Why?
Histones
2
2016
335
0.050
 Why?
Proportional Hazards Models
2
2015
430
0.050
 Why?
Janus Kinase 1
1
2021
20
0.050
 Why?
Janus Kinase 2
1
2021
31
0.050
 Why?
Gene Rearrangement
1
2022
76
0.050
 Why?
Organoids
1
2021
41
0.050
 Why?
Syndecan-1
1
2021
82
0.050
 Why?
Nitriles
1
2021
69
0.050
 Why?
Microarray Analysis
2
2012
85
0.050
 Why?
Biomarkers, Pharmacological
2
2011
28
0.050
 Why?
Chromosome Mapping
2
2011
175
0.050
 Why?
Pyrazoles
1
2021
110
0.050
 Why?
Polymerase Chain Reaction
2
2013
531
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
70
0.050
 Why?
Alternative Splicing
1
2021
64
0.050
 Why?
Cell Movement
1
2022
271
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
36
0.050
 Why?
Cell Line
2
2015
1152
0.050
 Why?
Phosphoproteins
1
2021
116
0.050
 Why?
Pyrimidines
1
2021
196
0.050
 Why?
Lymphoma, Follicular
1
2020
30
0.050
 Why?
Gene Expression
2
2013
664
0.050
 Why?
Protein Disulfide-Isomerases
1
2019
15
0.040
 Why?
Recurrence
1
2021
692
0.040
 Why?
Prospective Studies
2
2016
2606
0.040
 Why?
Maintenance Chemotherapy
1
2019
48
0.040
 Why?
Young Adult
2
2021
4318
0.040
 Why?
Syndrome
1
2019
253
0.040
 Why?
Physical Chromosome Mapping
1
2017
9
0.040
 Why?
Transcription Elongation, Genetic
1
2017
3
0.040
 Why?
Genetic Drift
1
2017
3
0.040
 Why?
Gene Knockdown Techniques
1
2018
125
0.040
 Why?
Unfolded Protein Response
1
2017
30
0.040
 Why?
Genetic Loci
1
2017
58
0.040
 Why?
Xenograft Model Antitumor Assays
1
2018
219
0.040
 Why?
Caspases
1
2018
146
0.040
 Why?
Molecular Targeted Therapy
1
2018
128
0.040
 Why?
Mitosis
1
2017
106
0.040
 Why?
Genetic Structures
1
2016
1
0.040
 Why?
Virus Integration
1
2016
9
0.040
 Why?
Genetic Association Studies
1
2017
136
0.040
 Why?
Comparative Genomic Hybridization
1
2016
50
0.040
 Why?
Risk
1
2017
343
0.040
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
41
0.030
 Why?
Tumor Microenvironment
1
2017
210
0.030
 Why?
Algorithms
1
2020
697
0.030
 Why?
Computational Biology
1
2018
231
0.030
 Why?
Nuclear Proteins
1
2017
253
0.030
 Why?
Immunosuppressive Agents
1
2017
248
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
16
0.030
 Why?
MafB Transcription Factor
1
2015
11
0.030
 Why?
Cytidine Deaminase
1
2015
13
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
20
0.030
 Why?
RNA Stability
1
2015
28
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
55
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
20
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
11
0.030
 Why?
Patient Selection
1
2016
284
0.030
 Why?
Cytogenetic Analysis
1
2014
90
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
6
0.030
 Why?
Amino Acid Sequence
1
2016
767
0.030
 Why?
Single-Cell Analysis
1
2014
56
0.030
 Why?
Introns
1
2014
49
0.030
 Why?
Antibodies, Monoclonal
1
2019
564
0.030
 Why?
Flow Cytometry
1
2017
547
0.030
 Why?
Methylation
1
2014
130
0.030
 Why?
Protein Isoforms
1
2014
124
0.030
 Why?
High-Throughput Screening Assays
1
2013
37
0.030
 Why?
Down-Regulation
1
2015
388
0.030
 Why?
Base Sequence
1
2015
719
0.030
 Why?
Time Factors
1
2021
3210
0.030
 Why?
Protein Structure, Tertiary
1
2014
289
0.030
 Why?
Osteonectin
1
2013
11
0.030
 Why?
HeLa Cells
1
2014
291
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
30
0.030
 Why?
Karyotyping
1
2013
92
0.030
 Why?
Azacitidine
1
2013
37
0.030
 Why?
Molecular Sequence Data
1
2015
980
0.030
 Why?
Early Detection of Cancer
1
2014
164
0.030
 Why?
Transforming Growth Factor beta1
1
2013
66
0.030
 Why?
Mass Spectrometry
1
2014
313
0.030
 Why?
Homologous Recombination
1
2013
43
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Tumor Suppressor Proteins
1
2013
141
0.030
 Why?
Gene Library
1
2012
50
0.030
 Why?
Laboratories
1
2012
21
0.030
 Why?
Hemizygote
1
2011
6
0.030
 Why?
Disease Models, Animal
1
2018
1647
0.030
 Why?
Drug Resistance, Neoplasm
1
2013
309
0.030
 Why?
Apoptosis
1
2018
1302
0.030
 Why?
Predictive Value of Tests
1
2014
1045
0.020
 Why?
Bone Marrow
1
2013
414
0.020
 Why?
Prednisolone
1
2010
57
0.020
 Why?
Animals
2
2018
14409
0.020
 Why?
Breast Neoplasms
1
2020
1249
0.020
 Why?
Vincristine
1
2010
98
0.020
 Why?
Cluster Analysis
1
2010
249
0.020
 Why?
Cyclophosphamide
1
2010
172
0.020
 Why?
Precancerous Conditions
1
2010
93
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
474
0.020
 Why?
Adolescent
1
2021
6900
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
151
0.020
 Why?
Stem Cell Transplantation
1
2010
201
0.020
 Why?
Clinical Trials as Topic
1
2012
491
0.020
 Why?
Doxorubicin
1
2010
259
0.020
 Why?
Child
1
2021
7368
0.020
 Why?
Sex Factors
1
2011
766
0.020
 Why?
Up-Regulation
1
2010
509
0.020
 Why?
Models, Biological
1
2012
825
0.020
 Why?
Risk Assessment
1
2013
1362
0.020
 Why?
Prevalence
1
2011
1025
0.020
 Why?
Mice
1
2018
6428
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (260) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department